Lijuan Deng

4.9k total citations · 2 hit papers
108 papers, 3.3k citations indexed

About

Lijuan Deng is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Lijuan Deng has authored 108 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 32 papers in Oncology and 28 papers in Pathology and Forensic Medicine. Recurrent topics in Lijuan Deng's work include Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (11 papers) and MicroRNA in disease regulation (7 papers). Lijuan Deng is often cited by papers focused on Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (11 papers) and MicroRNA in disease regulation (7 papers). Lijuan Deng collaborates with scholars based in China, United States and Ethiopia. Lijuan Deng's co-authors include Dongmei Zhang, Wen‐Cai Ye, Jiaxu Chen, Minfeng Chen, Caixia Sun, Qiao Sun, Zhen Li, Chongjun Zhao, Ming Qi and Ling Wen and has published in prestigious journals such as Journal of the American Statistical Association, Blood and PLoS ONE.

In The Last Decade

Lijuan Deng

104 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

One-pot solventless preparation of PEGylated black phosphorus nanoparticles for photoacoustic imaging and photothermal therapy of cancer

2016 419 citations Lijuan Deng et al. profile →
m6A modification: recent advances, anticancer targeted drug discovery and beyond

2022 252 citations Lijuan Deng, Minfeng Chen et al. Molecular Cancer profile →

Peers

Lijuan Deng

ONCOL

IMMUN

S. Asha Nair India

Soon‐Sun Hong South Korea

Min Young Kim South Korea

Consolación Melguizo Spain

José Prados Spain

Jian Liu China

Danyang Chen China

Ling Dong China

Yanan Liu China

Yu Ishima Japan

S. Asha Nair India

Lijuan Deng

2.0k ×1.2

891 ×1.4

ONCOL

592 ×1.2

348 ×0.7

299 ×0.7

IMMUN

Citations per year, relative to Lijuan Deng Lijuan Deng (= 1×) peers S. Asha Nair

Countries citing papers authored by Lijuan Deng

Since Specialization

Citations

This map shows the geographic impact of Lijuan Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijuan Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijuan Deng more than expected).

Fields of papers citing papers by Lijuan Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijuan Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijuan Deng. The network helps show where Lijuan Deng may publish in the future.

Co-authorship network of co-authors of Lijuan Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Lijuan Deng. A scholar is included among the top collaborators of Lijuan Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijuan Deng. Lijuan Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Sheng, Fangyuan Yang, Jiaxin Luo, et al.. (2025). Erianin inhibits the proliferation and stemness of pancreatic cancer cells by interacting with MEK1/2. Biochemical Pharmacology. 239. 117046–117046. 1 indexed citations

Ding, Nana, Jingbo Hu, Jun Tong, et al.. (2025). Xiaoyaosan improves depression-like behaviours in mice with post-stroke depression by modulating gut microbiota and microbial metabolism and regulating P2X7R/NLRP3 inflammasome. Phytomedicine. 145. 157078–157078. 1 indexed citations

Yan, Yan, Qian Wu, Jinhong Li, et al.. (2023). Chitosan inhibits vascular intimal hyperplasia via LINC01615/MIR-185-5p/PIK3R2 signaling pathway. Gene. 892. 147850–147850. 1 indexed citations

Li, Haiyang, Zixuan Yang, Lijuan Deng, et al.. (2023). Mutation divergence over space in tumour expansion. Journal of The Royal Society Interface. 20(208). 20230542–20230542. 2 indexed citations

Qiu, Wenqi, Qian Wu, Kaiwen Zhang, et al.. (2023). Xiaoyaosan ameliorates depressive-like behavior and susceptibility to glucose intolerance in rat: involvement of LepR-STAT3/PI3K pathway in hypothalamic arcuate nucleus. BMC Complementary Medicine and Therapies. 23(1). 116–116. 8 indexed citations

Huang, Maohua, et al.. (2023). Noninvasive Strategies for the Treatment of Tiny Liver Cancer: Integrating Photothermal Therapy and Multimodality Imaging EpCAM-Guided Nanoparticles. ACS Applied Materials & Interfaces. 15(18). 21843–21853. 5 indexed citations

Lin, Jiapeng, Maohua Huang, Lei Chen, et al.. (2023). Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of MDSCs through AKT/NF-κB pathway. Life Sciences. 324. 121715–121715. 11 indexed citations

Liu, Yanfei, et al.. (2023). Model for Predicting Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Discussion of Prophylaxis Measures. World Neurosurgery. 179. e387–e396. 1 indexed citations

Deng, Lijuan, Minfeng Chen, Ming Qi, et al.. (2022). m6A modification: recent advances, anticancer targeted drug discovery and beyond. Molecular Cancer. 21(1). 52–52. 252 indexed citations breakdown →

10.

Huang, Maohua, Chenran Wang, Lijuan Deng, et al.. (2022). New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects. Drug Resistance Updates. 64. 100849–100849. 101 indexed citations

11.

Hao, Wenzhi, Qian Chen, Lu Wang, et al.. (2022). Emerging roles of long non-coding RNA in depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 115. 110515–110515. 26 indexed citations

12.

Li, Zheng‐Xiang, Minfeng Chen, Jun Tang, et al.. (2021). Targeting FAPα-expressing tumor-associated mesenchymal stromal cells inhibits triple-negative breast cancer pulmonary metastasis. Cancer Letters. 503. 32–42. 19 indexed citations

13.

Deng, Lijuan, et al.. (2020). Leukaemia cutis as a specific skin involvement in chronic myelomonocytic leukaemia and review of the literature. Translational Cancer Research. 9(8). 4988–4998. 6 indexed citations

14.

Zhang, Jiayan, Mingqun Liu, Maohua Huang, et al.. (2019). Ginsenoside F1 promotes angiogenesis by activating the IGF-1/IGF1R pathway. Pharmacological Research. 144. 292–305. 82 indexed citations

15.

Zhu, Huizheng, Yudan Liang, Qingyu Ma, et al.. (2019). Xiaoyaosan improves depressive-like behavior in rats with chronic immobilization stress through modulation of the gut microbiota. Biomedicine & Pharmacotherapy. 112. 108621–108621. 141 indexed citations

16.

Liu, Jun-Shan, Lijuan Deng, Hai‐Yan Tian, et al.. (2019). Anti-tumor effects and 3D-quantitative structure-activity relationship analysis of bufadienolides from toad venom. Fitoterapia. 134. 362–371. 22 indexed citations

17.

Wang, Xiaopei, Yan Xie, Weiping Liu, et al.. (2018). Outcome and Prospective Factor Analysis of High-dose Therapy Combined with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Peripheral T-cell Lymphomas. International Journal of Medical Sciences. 15(9). 867–874. 11 indexed citations

18.

Zhuo, Zhenjian, Jianyang Hu, Xiaolin Yang, et al.. (2015). Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In Vivo. Scientific Reports. 5(1). 16185–16185. 87 indexed citations

19.

Ping, Lingyan, Ning Ding, Yunfei Shi, et al.. (2014). [Clinical characteristics and prognosis analysis of patients with LMP-1 positive Hodgkin's lymphoma after EBV infection].. PubMed. 22(1). 78–84. 4 indexed citations

20.

Liu, Fen, Huirong Ding, Xuan Jin, et al.. (2014). FCGR3A 158V/F Polymorphism and Response to Frontline R-CHOP Therapy in Diffuse Large B-Cell Lymphoma. DNA and Cell Biology. 33(9). 616–623. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact